Letrozole Sandoz Dosage & Drug Information

Concise Prescribing Info

Contents

Letrozole

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Indications/Uses

1st-line treatment in postmenopausal women w/ hormone-dependent advanced breast cancer. Advanced breast cancer after relapse or disease progression in women w/ natural or artificially induced postmenopausal endocrine status who have previously been treated w/ anti-estrogens. Adjuvant treatment of postmenopausal women w/ hormone receptor +ve invasive early breast cancer. Extended adjuvant treatment of invasive early breast cancer in postmenopausal women who have received prior standard adjuvant tamoxifen therapy for 5 yr.

Dosage/Direction for Use

Adult 2.5 mg once daily. Continue for 5 yr or until disease relapse/recurrence occurs, whichever comes 1st in the adjuvant & extended adjuvant setting. Continue until tumor progression is evident in patients w/ metastatic disease.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity. Premenopausal endocrine status. Pregnancy & lactation.

MIMS Class

Cancer Hormone Therapy

ATC Classification

L02BG04 - letrozole ; Belongs to the class of enzyme inhibitors. Used in treatment of neoplastic diseases.

Regulatory Classification

POM

Presentation/Packing

Form

Letrozole Sandoz FC tab 2.5 mg

Packing/Price

1's

Letrozole Sandoz

letrozole

Manufacturer:

Novartis Pharma Stein